Posts Feed
Comments Feed

Archive for the 'Compliance' Category

Economic Downturn Leads U.S. Residents To Skip, Delay Medical Care

The AP/Salt Lake Tribune on Wednesday examined how the “ailing economy is leading many Americans to skip doctor visits, skimp on their medicine, and put off mammograms, Pap smears and other tests,” a trend that physicians worry will result in “sicker patients who need more expensive treatment later.” A

More: continued here

No Comments »

How Safe Are Biological Medicines?

According to an article published in the October 22/29 issue of JAMA, about 25% of biological medicinal products that United States and European authorities have approved since 1995 have had at least one regulatory action issued due to safety within 10 years after approval. Around 11% of these antibody, enzyme, and insulin products have even received “black box” warnings that indicate the possibility of serious side effects.

More: continued here

No Comments »

Some U.S. Residents Cut Back On Prescription Drugs To Save Money

The New York Times on Wednesday examined how, as “people around the country respond to financial and economic hard times by juggling the cost of necessities like groceries and housing, drugs are sometimes having to wait.” An analysis conducted recently by IMS Health found that U.S.

More: continued here

No Comments »

« Prev - Next »

1